TY - JOUR
T1 - Hepatotoxic and carcinogenic effects of dimethylnitrosamine in low dosage. light and electron microscopic study
AU - Geil, J. H.
AU - Stenger, R. J.
AU - Behki, R. M.
AU - Morgan, W. S.
N1 - Funding Information:
2 Supported in part by American Cancer Society, Inc., institutional grants IN 57-E and IN 57-F to Western Reserve University, Public Health Service research grants AM 08416 and AM 07555 from the National Institute of Arthritis and Metabolic Diseases, and by a Career Development Award
PY - 1968/4
Y1 - 1968/4
N2 - Dimethylnitrosamine (DMN) in low dosage was administered continuously in drinking water to female rats. These animals and controls were killed at intervals through the 386th day of the experiment, and the liver parenchyma of each rat was studied by light and electron microscopy. Of the 9 liver tumors that developed, the 6 largest were hepatomas, which were similarly studied. The cytoplasmic changes induced in the liver parenchyma by the DMN treatment were comparable to those caused by other hepatotoxins and included disorganization of rough endoplasmic reticulum, proliferation of smooth endoplasmic reticulum, glycogen depletion, lipid accumulation, formation of autophagic vacuoles, and distortion of mitochondria. These alterations increased in frequency and intensity through the 289th day and then regressed. The only persistent cytoplasmic abnormalities at late stages of the experiment were moderately reduced glycogen stores and relatively hypertrophied smooth endoplasmic reticulum. The DMN treatment also induced hepatic nuclear and nucleolar changes, including focal condensations of the fibrillar component of the nucleolonema. First appearing after 170 days of treatment, the nucleolar alteration increased in frequency at subsequent intervals and continued throughout the experiment as a common, though not universal, feature of the parenchyma. The hepatoma cells displayed poor cytoplasmic differentiation, but their nuclei generally contained multiple, large nucleoli with focal condensations of the fibrillar component of the nucleolonema. It was concluded that the persistent nucleolar changes in the livers were more likely related to DMN hepatocarcinogenesis than the evanescent toxic alterations in the parenchymal cytoplasm.
AB - Dimethylnitrosamine (DMN) in low dosage was administered continuously in drinking water to female rats. These animals and controls were killed at intervals through the 386th day of the experiment, and the liver parenchyma of each rat was studied by light and electron microscopy. Of the 9 liver tumors that developed, the 6 largest were hepatomas, which were similarly studied. The cytoplasmic changes induced in the liver parenchyma by the DMN treatment were comparable to those caused by other hepatotoxins and included disorganization of rough endoplasmic reticulum, proliferation of smooth endoplasmic reticulum, glycogen depletion, lipid accumulation, formation of autophagic vacuoles, and distortion of mitochondria. These alterations increased in frequency and intensity through the 289th day and then regressed. The only persistent cytoplasmic abnormalities at late stages of the experiment were moderately reduced glycogen stores and relatively hypertrophied smooth endoplasmic reticulum. The DMN treatment also induced hepatic nuclear and nucleolar changes, including focal condensations of the fibrillar component of the nucleolonema. First appearing after 170 days of treatment, the nucleolar alteration increased in frequency at subsequent intervals and continued throughout the experiment as a common, though not universal, feature of the parenchyma. The hepatoma cells displayed poor cytoplasmic differentiation, but their nuclei generally contained multiple, large nucleoli with focal condensations of the fibrillar component of the nucleolonema. It was concluded that the persistent nucleolar changes in the livers were more likely related to DMN hepatocarcinogenesis than the evanescent toxic alterations in the parenchymal cytoplasm.
UR - http://www.scopus.com/inward/record.url?scp=0014273480&partnerID=8YFLogxK
U2 - 10.1093/jnci/40.4.713
DO - 10.1093/jnci/40.4.713
M3 - Article
C2 - 4296478
AN - SCOPUS:0014273480
SN - 0027-8874
VL - 40
SP - 713
EP - 730
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 4
ER -